Propofol inhibits Sox4 expression by regulating Wnt/β-catenin signaling pathway, thereby inhibiting the proliferation, migration and invasion of endometrial cancer cells and promoting apoptosis in a dose-dependent manner, which elucidated the molecular mechanism of propofol affecting endometrial cancer (Du et al., 2018). This evidence concerns the gene SOX4 and endometrial cancer.